Exagen Inc. vs Neuronetics, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Exagen Inc. is the larger company by market value: $218 M against $162 M for Neuronetics, Inc., 1.4 times as much (market caps of Oct 16, 2026 for Exagen Inc. and Oct 23, 2026 for Neuronetics, Inc.).
- Neuronetics, Inc. had more revenue: $149 M against $67 M for Exagen Inc., both in the year to December 2025.
- Both made a net loss: $20 M for Exagen Inc. and $39 M for Neuronetics, Inc.
- Neuronetics, Inc. keeps more of each dollar of sales: a net margin of -26.1% against -30.0% for Exagen Inc.
- Neuronetics, Inc.'s revenue grew faster in its latest fiscal year: +99.2% against +19.7% for Exagen Inc.
- On the Piotroski F-score, a nine-point test of improving finances, Exagen Inc. scores 3 and Neuronetics, Inc. 4. Both are in the distress zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Exagen Inc. XGN · #15,928 in the world | Neuronetics, Inc. STIM · #17,042 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | 2002 | 2003 |
| Size | ||
| Market cap | $218 M | $162 M |
| Revenue | $67 M | $149 M |
| Net income | $-20 M▲ best | $-39 M |
| Employees | 220 | — |
| Valuation | ||
| Price to sales | 3.0× | 1.0× |
| Price to book | 12.5× | 7.2× |
| Free cash flow yield | -6.5%▲ best | -13.1% |
| Profitability | ||
| Gross margin | 58.3%▲ best | 48.5% |
| Operating margin | -21.1% | -21.1%▲ best |
| Net margin | -30.0% | -26.1%▲ best |
| Return on equity | -147.8%▲ best | -155.7% |
| Growth | ||
| Revenue growth | 19.7% | 99.2%▲ best |
| Revenue growth, 3 years a year | 13.5% | 31.8%▲ best |
| Financial strength | ||
| Debt to equity | 1.3×▲ best | 2.9× |
| Interest cover | — | -4.1× |
| Cash | ||
| Free cash flow margin | -21.4% | -14.2%▲ best |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | 4 of 9▲ best |
| Altman Z-score zone | distress | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Exagen Inc. or Neuronetics, Inc.?
Exagen Inc. is the larger company by market value: $218 M against $162 M for Neuronetics, Inc., 1.4 times as much (market caps of Oct 16, 2026 for Exagen Inc. and Oct 23, 2026 for Neuronetics, Inc.).
Which makes more money, Exagen Inc. or Neuronetics, Inc.?
Neuronetics, Inc. had more revenue: $149 M against $67 M for Exagen Inc., both in the year to December 2025. Both made a net loss: $20 M for Exagen Inc. and $39 M for Neuronetics, Inc.
Which is more profitable, Exagen Inc. or Neuronetics, Inc.?
Neuronetics, Inc. keeps more of each dollar of sales: a net margin of -26.1% against -30.0% for Exagen Inc.
Which is growing faster, Exagen Inc. or Neuronetics, Inc.?
Neuronetics, Inc.'s revenue grew faster in its latest fiscal year: +99.2% against +19.7% for Exagen Inc.
Which is financially stronger, Exagen Inc. or Neuronetics, Inc.?
On the Piotroski F-score, a nine-point test of improving finances, Exagen Inc. scores 3 and Neuronetics, Inc. 4. Both are in the distress zone of the Altman Z-score.
More about Exagen Inc.
More about Neuronetics, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.